Furthermore, compared to chronological age alone or combined with the individual biomarkers, adding a brain biomarker for neurological degeneration (plasma NfL, total-tau, amyloid beta-40 and -42) further improved the association of biological age with dementia, including Alzheimer disease (AD). This evidence concerns the gene MAPT and Alzheimer disease.